J. Med. Chem., 49 (14), 4384 -4391, 2006. 10.1021/jm060277v S0022-2623(06)00277-9
Web Release Date: June 13, 2006

Copyright © 2006 American Chemical Society

A New Synthesis of Sulfonamides by Aminolysis of p-Nitrophenylsulfonates Yielding Potent and Selective Adenosine A2B Receptor Antagonists

Luo Yan, Daniela C. G. Bertarelli, Alaa M. Hayallah, Heiko Meyer, Karl-Norbert Klotz, and Christa E. Müller*

Pharmaceutical Institute, Pharmaceutical Chemistry Poppelsdorf, University of Bonn, Kreuzbergweg 26, D-53115 Bonn, Germany, Faculty of Pharmacy, Assiut University, Egypt, and Institute of Pharmacology and Toxicology, University of Würzburg, D-97078 Würzburg, Germany

Received March 13, 2006

Abstract:

1-Propyl- and 1,3-dimethyl-8-p-sulfophenylxanthine (PSB-1115 and SPT) were used as starting compounds for the development of adenosine A2B receptor antagonists with a sulfonamide structure. Since standard reactions for sulfonamide formation failed or resulted in very low yields, we developed a new method for the preparation of sulfonamides. p-Nitrophenoxide was used as a suitable leaving group with well balanced stability-reactivity properties. A large variety of amines, including aniline, benzylamine, phenethylamine, propylamine, butylamine, 2-hydroxyethylamine, aminoacetic acid, and N-benzylpiperazine reacted with p-nitrophenoxysulfonylphenylxanthine derivatives yielding the desired sulfonamides in satisfying to very good yields. The obtained sulfonamides were much more potent at A2B receptors than the parent sulfonates. The most active compound of the present series was 8-[4-(4-benzylpiperazide-1-sulfonyl)phenyl]-1-propylxanthine (11, PSB-601) exhibiting a Ki value of 3.6 nM for the human A2B receptor combined with high selectivity versus the other human adenosine receptor subtypes (575-fold versus A1, 134-fold versus A2A, and >278-fold versus A3).


Download the full text: PDF | HTML